Hubei Guangji Pharmaceutical Co.,Ltd. Posted 71.8 Million Yuan Net Loss in First Three Quarters of 2023

Hubei Guangji Pharmaceutical Co.,Ltd. (湖北广济药业股份有限公司) (000952.SZ) reported a net loss of 71.8 million yuan in the first three quarters of 2023, reversing a net profit of 18.3 million yuan for the same period in the previous year.

Meanwhile, the company posted 522.5 million yuan in revenue, down 2.6% year-on-year.

At the end of the reporting period, it had 3.2 billion yuan in total assets and 1.7 billion yuan in total liabilities, with a liability-to-asset ratio of 53.3%.